Evidence map›Paper›PMID 38973727›Full record

ReviewACS applied materials & interfaces2025

Near Infrared Biomimetic Hybrid Magnetic Nanocarrier for MRI-Guided Thermal Therapy.

João Victor Ribeiro Rocha, Rafael Freire Krause, Carlos Eduardo Ribeiro, Nathália Corrêa de Almeida Oliveira, Lucas Ribeiro de Sousa, Juracy Leandro Santos, Samuel de Melo Castro, Marize Campos Valadares, Mauro Cunha Xavier Pinto, Marcilia Viana Pavam and 3 more

Abstract readReview
In one paragraph

Review in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Exosome-mediated siRNA delivery in cancer: Loading strategies, targeting approaches, and therapeutic outcomes.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2026
    Review
  2. Review
  3. Unveiling Dipolar Interaction-Driven Magnetic Field Inhomogeneities in TAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

João Victor Ribeiro RochaInstitute of Physics, Federal University of Goiás, Goianiâ, Goiás 74690-900, Brazil.
Rafael Freire KrauseInstitute of Physics, Federal University of Goiás, Goianiâ, Goiás 74690-900, Brazil.
Carlos Eduardo RibeiroInstitute of Physics, Federal University of Goiás, Goianiâ, Goiás 74690-900, Brazil.
Nathália Corrêa de Almeida OliveiraFarmaTec - Laboratory of Pharmaceutical Technology, Federal University of Goiás, Goianiâ, Goiás 74690-631, Brazil.
Lucas Ribeiro de SousaInstitute of Physics, Federal University of Goiás, Goianiâ, Goiás 74690-900, Brazil.
Juracy Leandro SantosInstitute of Physics, Federal University of Goiás, Goianiâ, Goiás 74690-900, Brazil.
Samuel de Melo CastroInstitute of Physics, Federal University of Goiás, Goianiâ, Goiás 74690-900, Brazil.
Marize Campos ValadaresToxIn - Laboratory of Education and Research in In Vitro Toxicology, Federal University of Goiás, Goianiâ, Goiás 74690-631, Brazil.
Mauro Cunha Xavier PintoDepartment of Pharmacology, Institute of Biological Sciences, Federal University of Goiás, Goianiâ, Goiás 74690-900, Brazil.ORCID 0000-0002-1680-8130
Marcilia Viana PavamFarmaTec - Laboratory of Pharmaceutical Technology, Federal University of Goiás, Goianiâ, Goiás 74690-631, Brazil.
Eliana Martins LimaFarmaTec - Laboratory of Pharmaceutical Technology, Federal University of Goiás, Goianiâ, Goiás 74690-631, Brazil.ORCID 0000-0003-1231-5803
Sebastião Antônio MendanhaInstitute of Physics, Federal University of Goiás, Goianiâ, Goiás 74690-900, Brazil.
Andris Figueiroa BakuzisInstitute of Physics, Federal University of Goiás, Goianiâ, Goiás 74690-900, Brazil.ORCID 0000-0003-3366-106X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell-membrane hybrid nanoparticles (NPs) are designed to improve drug delivery, thermal therapy, and immunotherapy for several diseases. Here, we report the development of distinct biomimetic magnetic nanocarriers containing magnetic nanoparticles encapsulated in vesicles and IR780 near-infrared dyes incorporated in the membranes. Distinct cell membranes are investigated, red blood cell (RBC), melanoma (B16F10), and glioblastoma (GL261). Hybrid nanocarriers containing synthetic lipids and a cell membrane are designed. The biomedical applications of several systems are compared. The inorganic nanoparticle consisted of Mn-ferrite nanoparticles with a core diameter of 15 ± 4 nm. TEM images show many multicore nanostructures (∼40 nm), which correlate with the hydrodynamic size. Ultrahigh transverse relaxivity values are reported for the magnetic NPs, 746 mM

Indexed as

Biomimetic MaterialsHyperthermia, InducedMagnetic Resonance ImagingMagnetite NanoparticlesAnimalsCell Line, TumorFerric CompoundsHumansIndolesInfrared RaysLiposomesManganese CompoundsMicePhotothermal TherapyFerric CompoundsIndolesLiposomesMagnetite NanoparticlesManganese Compoundscancercell membrane nanoparticlesglioblastoma.SPIONthermal nanomedicine

Identifiers

PMID38973727
PMCPMC11891835

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.